Vaccinating Newborns Against STDs
Jul 20, 2011 1:05:52 GMT -5
Post by PrisonerOfHope on Jul 20, 2011 1:05:52 GMT -5
So many sheeple do what they're told without doing any research or thinking for themselves. In this case, a relatively large percentage would have their newborn babies and themselves vaccinated against HPV - a sexually transmitted disease - because their obstetricians recommended it! Never mind that Gardisil has caused horrific side effects, including the deaths of many young girls who were injected in it, but it's "effective" for only a limited time! (I don't believe any vaccine is truly effective.) This is yet another case of Big Pharma wanting to make even more money, regardless of who gets hurt or even killed in the process. 
Willingness of pregnant women to vaccinate themselves and their newborns with the HPV vaccine
Katherine P. Heymana, Michael J. Worley Jrb, Melissa K. Freyb, Robin T. Kesslerb, Diane C. Bodurkac and Brian M. Slomovitzd, Corresponding Author Contact Information, E-mail The Corresponding Author
a Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10021, United States
b Department of Obstetrics and Gynecology, New York Presbyterian Hospital-Cornell University Medical Center, New York, NY, United States
c Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
d Department of Gynecologic Oncology, Morristown Memorial Hospital, Morristown, NJ, United States
Received 25 October 2010;
accepted 17 April 2011.
Available online 8 May 2011.
Abstract
Objective
To evaluate the willingness of pregnant women to accept the HPV vaccine for their newborns as well as themselves.
Methods
An 18-item questionnaire was distributed to antepartum women. Demographic data about the respondent's current pregnancy and her knowledge of HPV and the HPV vaccine was collected. Information about the respondent's HPV and HPV vaccine status as well as her acceptance of the vaccine for herself during pregnancy and her newborn son and/or daughter after delivery was also collected.
Results
Three hundred surveys were completed and available for review. Only 6 respondents (2%) had received the HPV vaccine. Despite the small group of patients who had previously been vaccinated, 112 respondents (37.3%) stated that they would receive the HPV vaccine during pregnancy if recommended by an obstetrician. 99 respondents (33%) stated that they would vaccinate their newborn female infant and 83 (27.7%) stated would vaccinate their male infants.
Conclusion
Providing the HPV vaccine to pregnant women as well as newborns could be an important way to increase the patient population who is protected against HPV. A percentage of pregnant women are willing to accept the vaccine for themselves and their newborns.
www.sciencedirect.com/science/article/pii/S0264410X11006074
Willingness of pregnant women to vaccinate themselves and their newborns with the HPV vaccine
Katherine P. Heymana, Michael J. Worley Jrb, Melissa K. Freyb, Robin T. Kesslerb, Diane C. Bodurkac and Brian M. Slomovitzd, Corresponding Author Contact Information, E-mail The Corresponding Author
a Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10021, United States
b Department of Obstetrics and Gynecology, New York Presbyterian Hospital-Cornell University Medical Center, New York, NY, United States
c Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
d Department of Gynecologic Oncology, Morristown Memorial Hospital, Morristown, NJ, United States
Received 25 October 2010;
accepted 17 April 2011.
Available online 8 May 2011.
Abstract
Objective
To evaluate the willingness of pregnant women to accept the HPV vaccine for their newborns as well as themselves.
Methods
An 18-item questionnaire was distributed to antepartum women. Demographic data about the respondent's current pregnancy and her knowledge of HPV and the HPV vaccine was collected. Information about the respondent's HPV and HPV vaccine status as well as her acceptance of the vaccine for herself during pregnancy and her newborn son and/or daughter after delivery was also collected.
Results
Three hundred surveys were completed and available for review. Only 6 respondents (2%) had received the HPV vaccine. Despite the small group of patients who had previously been vaccinated, 112 respondents (37.3%) stated that they would receive the HPV vaccine during pregnancy if recommended by an obstetrician. 99 respondents (33%) stated that they would vaccinate their newborn female infant and 83 (27.7%) stated would vaccinate their male infants.
Conclusion
Providing the HPV vaccine to pregnant women as well as newborns could be an important way to increase the patient population who is protected against HPV. A percentage of pregnant women are willing to accept the vaccine for themselves and their newborns.
www.sciencedirect.com/science/article/pii/S0264410X11006074
